Skip to main content

Washington To Get $371.8M To Fight Opioid Crisis

Washington To Get $371.8M To Fight Opioid Crisis

Washington To Get $371.8M To Fight Opioid Crisis

Introduction

Following the settlement of a lawsuit against opioid-producing and -selling businesses, the state of Washington will receive $371.8 million to combat opioid addiction, according to the state Attorney General's Office.

The 125 local governments in the state will each receive half of that sum, and they must utilize the money on opioid cleanup. The state will receive the remainder. King County and its communities will get more than $100 million. About $26 million will be spent only in Seattle. Pierce County will receive $48.2 million, and Snohomish County will receive $47.3 million.

Four separate settlements with CVS, Walgreens, Teva, and Allergan provided the funding. In the two biggest, Walgreens will pay $120 million to Washington over a 15-year period, while CVS will contribute $110 million over a 10-year period.

In accordance with the agreements, CVS and Walgreens would "tightly monitor" the opioid prescriptions they write and stop patients from requesting numerous opioid prescriptions. Teva cannot advertise opioids, and Allergan will stop selling opioids for ten years. The resolution was approved by all of the relevant municipal governments.

The Attorney General stated in a news release that these resources are being distributed to all areas of the state to confront the fentanyl issue and enhance treatment alternatives. Our neighborhoods will be safer, and lives will be saved.

A $518 million settlement with three of the biggest opioid distributors in the country—Mckesson Corp., Cardinal Health Inc., and AmerisourceBergen Drug Corp.—was announced by the attorney general last year.

The money can be applied to housing, education, naloxone distribution, school-based programs, and first responder support in order to meet opioid rehabilitation standards.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Purdue, Sacklers Agree to New $7.4B Opioid Settlement

Categories: Opioids

All 50 U.S. states, along with the District of Columbia and U.S. territories, have agreed to a $7.4 billion settlement with Purdue Pharma, the manufacturer of OxyContin.

This deal addresses allegations that the company’s aggressive and…

Oregon to Get $66M in Sackler Opioid Settlement

Categories: Opioids

Oregon will gain $66 million as part of a nationwide settlement with the Sackler family and Purdue Pharma, the makers of OxyContin. The funds will be used to expand and…

Study Finds Toxic Metals in E-Cigs and U-Cigs Vapors

Categories: E-Cigarette: JUUL

As health concerns about e-cigarette use escalate, emerging research suggests that a newer class of vaping products—ultrasonic cigarettes or u-cigarettes—may pose even greater risks.

A study published in Environmental Health Perspectives in…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!